Billy Goat Brands

Billy Goat Brands Joins SeaLegacy's Good Ocean Supporting Critical Ocean Conservation Work

  • The Company's Commitment is Aligned with its Focus on the Oceans and Proactive Attentiveness to the Growing Consumer Demand for Accountability in how Products are Made, Sold and Marketed
  • SeaLegacy a Global Non-Profit Using the Power of Media and Storytelling to Amplify Ocean Solutions
  • Funds Raised Through SeaLegacy's Good Ocean Support Impact Grants to Organizations Leading On-the-Ground Projects that Conserve Oceans While Building a More Just and Equitable Planet
  • SeaLegacy and its Co-Founders Boast a Combined Audience of Over 10 Million Instagram Followers

Billy Goat Brands Ltd. ("GOAT" or the "Company") (CSE: GOAT) (OTCQB: BGTTF) (FRA: 26B), a venture capital platform focused on identifying, sponsoring and incubating high-potential companies in the ocean economy, is pleased to announce a one-year commitment to SeaLegacy (" SeaLegacy ") through The Good Ocean (" Good Ocean " or the " Program "). SeaLegacy is an organization that uses a variety of collaborations, experts and the latest digital and social technologies to aid in the building of a healthy future for oceans across the world. The Good Ocean is a community of businesses that supports SeaLegacy's mission and aligns with its values to create a better planet. GOAT is dedicated to making a difference when it comes to the sustainability of oceans through sustainable commerce, which is reinforced by its sponsorship of the Program.

The Company will be acknowledged on SeaLegacy's established social media network and website, be exposed to exclusive networking opportunities, have access to visual assets provided by SeaLegacy and the Program, as well as work with the communications team to create other bespoke amplification opportunities. SeaLegacy has a wide reach with 2.4 million followers on its @sealegacy Instagram account, while its Co-Founders Cristina Mittermeier and Paul Nicklen have 1.5 million and 7.3 million followers on their @mitty and @paulnicklen Instagram accounts, respectively. Therefore, the SeaLegacy team is creating ocean conservation awareness on an unmatched scale.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/42670a42-d7f5-468c-8c4d-5d301657415c

Members of The Good Ocean share a common love of the ocean and are eager to help reverse the destruction that is currently occurring. More than 70% of the planet is covered in water, and yet less than 2% of the ocean is fully protected. 1 The Program is unified, passionate, and takes a business approach to increase the protection of the world's oceans. GOAT, as a new member of The Good Ocean, is committing to supporting the development of a more sustainable ocean economy through its operations and investments. SeaLegacy aligns with businesses who genuinely care about their impact on the ocean – and the planet – and are proactively attentive to the growing consumer demand for accountability in how products are made, sold and marketed.

Additionally, The Good Ocean has recently announced a partnership with the Professional Association of Diving Instructors (PADI) to accelerate the protection of 30% of the ocean by 2030 and is participating in a campaign to protect the New Zealand shark community from poaching. More information on The Good Ocean can be found on its website: https://www.sealegacy.org/pages/good-ocean .

Management Commentary

"SeaLegacy's Good Ocean is a community of passionate and proactive businesses unified by an ability and commitment to disrupt their industry," said Cristina Mittermeier, Co-founder and President of SeaLegacy. "Our members are leaders in their space, responding to the growing consumer demand for accountability in how products are produced, distributed and packaged. I am honored that the team at GOAT has chosen to align with SeaLegacy, and together, we can take steps towards systemic change in our consumer culture," added Ms. Mittermeier.

"GOAT is a proud new member of SeaLegacy's Program, which is a growing community of aligned businesses guided by a commitment to respond quickly to the urgent need to make systemic changes in consumer habits regarding our oceans. We are excited to participate in making sustainable choices and encouraging other businesses to do the same, while encouraging strong returns on investment and high levels of customer satisfaction," said Tony Harris, Chairman and Chief Executive Officer of GOAT.

ABOUT SEALEGACY

SeaLegacy, in partnership with action hub Only One, is building a global movement of ocean activists who support critical ocean conservation and climate solutions — to drive meaningful change for our planet in this decade. Founded by Cristina Mittermeier, Paul Nicklen and Shawn Heinrichs, SeaLegacy leverages compelling visual storytelling content to move people from apathy to action, countering climate anxiety by connecting people everywhere with opportunities to catalyze change, fund innovative solutions, and drive significant impact for the ocean and our planet. More information about SeaLegacy can be found on its website: https://www.sealegacy.org .

ABOUT BILLY GOAT BRANDS

Billy Goat Brands is a venture capital platform focused on identifying, sponsoring and incubating high-potential companies in the ocean economy. It intends to accomplish these goals through the identification of and investment in the securities of private businesses that are involved in the food and beverage industry, with a focus on: (i) plant-based protein, (ii) functional foods, (iii) food technology, and (iv) sustainable packaging technologies. The Company plans to generate returns on its investments through various outcomes, including but not limited to go-public transactions, mergers or acquisitions, and the other liquidity events of its investee companies or projects. The paramount goal of Billy Goat Brands will be to generate maximum returns from its investments in a manner consistent with its environmental, social and governance values.

For more information about the Company, please visit https://billygoatbrands.com/ . Its final prospectus, financial statements and management's discussion and analysis, among other documents, are all available on the Company's profile page on SEDAR at www.sedar.com .

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

On behalf of:

Billy Goat Brands Ltd.

"Tony Harris"

Tony Harris, CEO & Chairman
Tel: (778) 222-8221

For further information, please contact:

Investor Relations
Email: info@billygoatbrands.com
Tel: 1-833-4-GOAT-IR (1-833-446-2847)

CAUTIONARY STATEMENT REGARDING "FORWARD-LOOKING" INFORMATION

This news release contains certain forward-looking statements within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. The Company has provided the forward-looking statements in reliance on assumptions that it believes are reasonable at this time. All such forward-looking statements involve substantial known and unknown risks and uncertainties (including those risk factors identified in the Company's prospectus dated September 8, 2021), certain of which are beyond the Company's control. Such risks and uncertainties include, without limitation, delays resulting from or inability to obtain required regulatory approval. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as expressly required by applicable law.

Endnotes

  1. "Urge world leaders to protect 30% of the ocean by 2030", Only One Inc., 2022, https://only.one/act/ocean30

SOURCE: Billy Goat Brands Ltd.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GOAT:CC
The Conversation (0)
GOAT Enters Into Letter of Intent to Acquire Canadian License for Direct Lithium Extraction Technology

GOAT Enters Into Letter of Intent to Acquire Canadian License for Direct Lithium Extraction Technology

GOAT Industries Ltd. (the " Company " or " GOAT ") (CSE: GOAT), is pleased to announce the Company has entered into a non-binding Letter of Intent (the " LOI ") dated September 14, 2022 with 1000288601 Ontario Inc. (" Ontario Co ").

The LOI contemplates a proposed transaction (the " Proposed Transaction "), whereby GOAT would acquire all issued and outstanding securities of Ontario Co by way of a share exchange agreement (the " Share Exchange "). Ontario Co is in the process of acquiring the Canadian license for a Direct Lithium Extraction technology (the " DLE Technology ") developed by private industry, as well as University researchers based out of Australia.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
GOAT Announces Corporate Rebrand

GOAT Announces Corporate Rebrand

GOAT Industries Ltd. (the " Company " or " GOAT ") (CSE: GOAT), is pleased to report that in conjunction with its name change to GOAT Industries Ltd., the Company has launched its rebranded corporate website and investor presentation which can be viewed at: https:www.goatindustries.co .

GOAT's Management encourages all shareholders to visit the website and explore its redesign initiatives.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Billy Goat Provides H2 Guidance for FunGuys Beverages

Billy Goat Provides H2 Guidance for FunGuys Beverages

Billy Goat Brands Ltd. (the " Company " or " GOAT ") (CSE: GOAT), is pleased to report that FunGuys Beverages (" FunGuys "), a 100-per-cent wholly owned subsidiary of GOAT has successfully achieved Phase II certification of TerraCycle's LOOP (" LOOP ") testing protocols. This operational milestone further demonstrates FunGuys's market position as a socially responsible distributor of organic mushroom-infused cold brew coffee beverages underpinned by proprietary formulation stack.

FunGuys's commercial associations with LOOP enables it to leverage reusable packaging for its line of Kold-branded beverages. As previously announced, LOOP's stringent design guidelines will enable Kold products to move from single-use packaging to a multiuse ecosystem while also providing FunGuys with access to a scalable sales channel through LOOP 's integrated network of retail partners. Recently, LOOP was invited to present its views on sustainable business practices at the World Economic Forum and has support from major North American and European grocers, retailers and packaged good brands.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Billy Goat Brands Announces Name Change

Billy Goat Brands Announces Name Change

Billy Goat Brands Ltd. (the " Company " or " GOAT ") (CSE: GOAT), is pleased to announce that, subject to the approval of the Canadian Securities Exchange (" CSE "), effective September 12, 2022, the Company intends to change its name to "GOAT Industries Ltd." from "Billy Goat Brands Ltd." (the " Name Change ") The Company will continue to trade under the stock symbol "GOAT" on the CSE, under the stock symbol "BGTTF" on the OTCQB Venture Market and under the symbol "26B" on the Frankfurt Stock Exchange.

No action is required to be taken by shareholders with respect to the name change. Outstanding share certificates are not affected by the name change and do not need to be exchanged. The Company's ISIN and CUSIP numbers for the common shares will change to CA3802J1030 and 38021J103, respectively.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Billy Goat Acquires Kojo Pet Performance

Billy Goat Acquires Kojo Pet Performance

Billy Goat Brands Ltd. (the " Company " or " Billy Goat ") (CSE: GOAT), is pleased to announce that further to its news release dated June 30, 2022, it has completed the acquisition of Kojo Pet Performance Inc. (" Kojo ") in consideration of 25,000,000 common shares of the Company (each a " Consideration Share ") issued at a deemed price of $0.039 per share to the existing shareholders of Kojo (collectively, the " Vendors "). Kojo is an innovative pet-food brand focused on producing and marketing plant and cell-based pet food offerings.

Furthermore, the Vendors are eligible to earn up to an additional 30,000,000 Consideration Shares upon the realization of the following performance milestones by Kojo within 36 months from the date of closing:

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
  TrivarX

Positive results from Phase 2 Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) Study

TrivarX Limited (‘the Company’) (ASX: TRI) is pleased to announce positive top-line results from the Company’s recently completed Phase 2 Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) study utilising its proprietary AI-backed algorithm, MEB-001. MEB-001 uses EEG and ECG signals recorded during sleep to identify current Major Depressive Episode (cMDE).

Keep reading...Show less
Tryptamine Therapeutics Limited

Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy

Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP), a clinical-stage biotechnology company is pleased to advise it has received highly encouraging, positive results from its recently completed Phase 2a clinical trial conducted in collaboration with the University of Michigan (‘UOM’) (refer ASX announcement: 10 July 2024). The results are both significant and clinically meaningful, and were presented by UOM researchers at the International Association for the Study of Pain (‘IASP’) 2024 World Congress in the Netherlands on 9 August 2024.

Keep reading...Show less
  LTR Pharma Limited

LTP Secures Global Co-Development Agreement with Aptar Pharma

LTR Pharma Limited (ASX:LTR) (“LTR Pharma”, “the Company”) is pleased to announce that it has entered into a Co-Development Agreement (“the Agreement”) for SPONTAN for global markets.

Keep reading...Show less
CHIMERIC THERAPEUTICS LIMITED

First Patient Enrolled in CHM CDH17 Phase 1/2 Clinical Trial

Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), an Australian leader in cell therapy, is pleased to announce that the first participant has been enrolled in the Phase 1/2 multi-centre clinical trial for CHM CDH17 cell therapy.

Keep reading...Show less
Tryptamine Therapeutics Limited

Successful Maiden Dosing of TRP-8803 (IV-Infused Psilocin) Completed in Global First

Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP), a clinical-stage biotechnology company focused on the development of an innovative and scalable intravenous-infused psilocin formulation which may be used in conjunction with psychotherapy to address significant unmet medical needs, is pleased to advise that it has successfully and safely completed the world’s first participant dosing using TRP-8803 (IV-infused psilocin) in a patient in Adelaide, South Australia.

Keep reading...Show less
Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension  of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies

Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies

  • Bexicaserin achieved an overall median seizure reduction of 56.1% in countable motor seizures over an approximate 6-month treatment period; participants randomized to the PACIFIC placebo group achieved a median seizure reduction of 57.3%
  • Favorable safety and tolerability results observed
  • 100% of participants who completed the PACIFIC Study entered the OLE
  • End of Phase 2 Meeting scheduled for this summer

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced positive interim results from its ongoing 52-week open-label extension of the PACIFIC Study evaluating bexicaserin (LP352) in participants ages 12-65 years old with Developmental and Epileptic Encephalopathies.

"We are thrilled to see a sustained, durable response in seizure reduction and a favorable safety and tolerability profile across a broad range of DEE patients. Additionally, we saw compelling seizure reduction in the PACIFIC placebo patients who transitioned to bexicaserin in the OLE. These data provide further support to bexicaserin's potential to offer a highly differentiated and best-in-class profile," stated Dr. Randall Kaye, Longboard's Chief Medical Officer.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×